175 related articles for article (PubMed ID: 2481268)
1. Increased Sp1 binding mediates erythroid-specific overexpression of a mutated (HPFH) gamma-globulin promoter.
Ronchi A; Nicolis S; Santoro C; Ottolenghi S
Nucleic Acids Res; 1989 Dec; 17(24):10231-41. PubMed ID: 2481268
[TBL] [Abstract][Full Text] [Related]
2. The T----C substitution at -198 of the A gamma-globin gene associated with the British form of HPFH generates overlapping recognition sites for two DNA-binding proteins.
Fischer KD; Nowock J
Nucleic Acids Res; 1990 Oct; 18(19):5685-93. PubMed ID: 1699206
[TBL] [Abstract][Full Text] [Related]
3. Increased erythroid-specific expression of a mutated HPFH gamma-globin promoter requires the erythroid factor NFE-1.
Nicolis S; Ronchi A; Malgaretti N; Mantovani R; Giglioni B; Ottolenghi S
Nucleic Acids Res; 1989 Jul; 17(14):5509-16. PubMed ID: 2474800
[TBL] [Abstract][Full Text] [Related]
4. The effects of HPFH mutations in the human gamma-globin promoter on binding of ubiquitous and erythroid specific nuclear factors.
Mantovani R; Malgaretti N; Nicolis S; Ronchi A; Giglioni B; Ottolenghi S
Nucleic Acids Res; 1988 Aug; 16(16):7783-97. PubMed ID: 2458563
[TBL] [Abstract][Full Text] [Related]
5. Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression.
Jane SM; Gumucio DL; Ney PA; Cunningham JM; Nienhuis AW
Mol Cell Biol; 1993 Jun; 13(6):3272-81. PubMed ID: 7684493
[TBL] [Abstract][Full Text] [Related]
6. HMG-I binds to GATA motifs: implications for an HPFH syndrome.
Magis W; Martin DI
Biochem Biophys Res Commun; 1995 Sep; 214(3):927-33. PubMed ID: 7575565
[TBL] [Abstract][Full Text] [Related]
7. A naturally occurring gamma globin gene mutation enhances SP1 binding activity.
Sykes K; Kaufman R
Mol Cell Biol; 1990 Jan; 10(1):95-102. PubMed ID: 1688466
[TBL] [Abstract][Full Text] [Related]
8. DNA sequences regulating human globin gene transcription in nondeletional hereditary persistence of fetal hemoglobin.
Ottolenghi S; Mantovani R; Nicolis S; Ronchi A; Giglioni B
Hemoglobin; 1989; 13(6):523-41. PubMed ID: 2481658
[TBL] [Abstract][Full Text] [Related]
9. The deletion of the distal CCAAT box region of the A gamma-globin gene in black HPFH abolishes the binding of the erythroid specific protein NFE3 and of the CCAAT displacement protein.
Mantovani R; Superti-Furga G; Gilman J; Ottolenghi S
Nucleic Acids Res; 1989 Aug; 17(16):6681-91. PubMed ID: 2476717
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the mechanism of action of the Brazilian type (Agamma-195 C --> G) of hereditary persistence of fetal hemoglobin.
Takahashi T; Schreiber R; Krieger JE; Saad ST; Costa FF
Eur J Haematol; 2003 Dec; 71(6):418-24. PubMed ID: 14703691
[TBL] [Abstract][Full Text] [Related]
11. Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor.
Martin DI; Tsai SF; Orkin SH
Nature; 1989 Mar; 338(6214):435-8. PubMed ID: 2467208
[TBL] [Abstract][Full Text] [Related]
12. Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin.
Gumucio DL; Rood KL; Gray TA; Riordan MF; Sartor CI; Collins FS
Mol Cell Biol; 1988 Dec; 8(12):5310-22. PubMed ID: 2468996
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the mechanism of action of non-deletion hereditary persistence of fetal hemoglobin mutants in transgenic mice.
Li Q; Duan ZJ; Stamatoyannopoulos G
EMBO J; 2001 Jan; 20(1-2):157-64. PubMed ID: 11226166
[TBL] [Abstract][Full Text] [Related]
14. The -175T----C mutation increases promoter strength in erythroid cells: correlation with evolutionary conservation of binding sites for two trans-acting factors.
Gumucio DL; Lockwood WK; Weber JL; Saulino AM; Delgrosso K; Surrey S; Schwartz E; Goodman M; Collins FS
Blood; 1990 Feb; 75(3):756-61. PubMed ID: 1688723
[TBL] [Abstract][Full Text] [Related]
15. An erythroid-specific DNA binding factor mediates increased gamma-globin expression in hereditary persistence of fetal hemoglobin (HPFH).
Martin DI; Orkin SH
Prog Clin Biol Res; 1989; 316A():217-28. PubMed ID: 2480608
[No Abstract] [Full Text] [Related]
16. Comparative studies of nondeletional HPFH gamma-globin gene promoters.
Motum PI; Lindeman R; Harvey MP; Trent RJ
Exp Hematol; 1993 Jul; 21(7):852-8. PubMed ID: 7686501
[TBL] [Abstract][Full Text] [Related]
17. Induction of an embryonic globin gene promoter by short-chain fatty acids.
Dempsey NJ; Ojalvo LS; Wu DW; Little JA
Blood; 2003 Dec; 102(12):4214-22. PubMed ID: 12920040
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the human fetal-to-adult globin switching.
Katsube T; Fucharoen S; Tojo H; Fukumaki Y
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():212-20. PubMed ID: 8629109
[TBL] [Abstract][Full Text] [Related]
19. A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression.
Fucharoen S; Shimizu K; Fukumaki Y
Nucleic Acids Res; 1990 Sep; 18(17):5245-53. PubMed ID: 1698280
[TBL] [Abstract][Full Text] [Related]
20. Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements.
Walters M; Martin DI
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10444-8. PubMed ID: 1438231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
